{"nctId":"NCT00463437","briefTitle":"Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines","startDateStruct":{"date":"2007-04-25","type":"ACTUAL"},"conditions":["Hepatitis B","Acellular Pertussis","Tetanus","Poliomyelitis","Diphtheria","Streptococcus Pneumoniae Vaccines"],"count":1437,"armGroups":[{"label":"GSK's 10-valent Pneumococcal Vaccine 1024850A + Meningitec™","type":"EXPERIMENTAL","interventionNames":["Biological: Pneumococcal conjugate vaccine GSK1024850A","Biological: Infanrix hexa","Biological: Infanrix IPV Hib","Biological: Meningitec"]},{"label":"GSK's 10-valent Pneumococcal Vaccine 1024850A + NeisVac-C™","type":"EXPERIMENTAL","interventionNames":["Biological: Pneumococcal conjugate vaccine GSK1024850A","Biological: Infanrix hexa","Biological: Infanrix IPV Hib","Biological: NeisVac-C"]},{"label":"GSK's 10-valent Pneumococcal Vaccine 1024850A + Menitorix™","type":"EXPERIMENTAL","interventionNames":["Biological: Pneumococcal conjugate vaccine GSK1024850A","Biological: Infanrix penta","Biological: Infanrix IPV","Biological: Menitorix"]},{"label":"Prevenar™ + Menitorix™","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Prevenar","Biological: Infanrix penta","Biological: Infanrix IPV","Biological: Menitorix"]}],"interventions":[{"name":"Pneumococcal conjugate vaccine GSK1024850A","otherNames":[]},{"name":"Prevenar","otherNames":["Pneumococcal conjugate vaccine (Wyeth Lederle)."]},{"name":"Infanrix hexa","otherNames":["DTPa-HBV-IPV/Hib (GSK Biologicals)."]},{"name":"Infanrix IPV Hib","otherNames":["DTPa-IPV/Hib (GSK Biologicals)."]},{"name":"Infanrix penta","otherNames":["DTPa-HBV-IPV (GSK Biologicals)."]},{"name":"Infanrix IPV","otherNames":["DTPa-IPV (GSK Biologicals)"]},{"name":"Meningitec","otherNames":["Meningococcal C conjugate vaccine (Wyeth)."]},{"name":"NeisVac-C","otherNames":["Meningococcal C conjugate vaccine (Baxter)."]},{"name":"Menitorix","otherNames":["Combined Hib-MenC vaccine (GSK Biologicals)."]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who the investigator believes that their parents/guardians can and will comply with the requirements of the protocol.\n* A male or female between, and including, 11-18 months of age at the time of the booster vaccination.\n* A male or female who previously participated in study 107005 and received three doses of pneumococcal conjugate vaccine.\n* Written informed consent obtained from the parent or guardian of the subject.\n* Free of obvious health problems as established by medical history and clinical examination before entering into the study.\n\nExclusion Criteria:\n\n* Concurrently participating in another clinical study, at any time during the study period (active phase and extended safety follow-up), in which the subject has been or will be exposed to an investigational or a non-investigational product.\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccines within one month preceding the booster dose of study vaccines, or planned use during the entire study period\n* Chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs within 6 months prior to the booster dose of study vaccines.\n* Planned administration/administration of a vaccine not foreseen by the study protocol, during the period starting one month before the booster dose of study vaccines and up to the follow-up visit (one month after the booster dose of study vaccines).\n* Administration of any pneumococcal, diphtheria, tetanus, pertussis, polio, hepatitis B, Haemophilus influenzae type b, MenC and/or Hib-MenC vaccines other than the study vaccines from study 107005.\n* History of, or intercurrent, diphtheria, tetanus, pertussis, polio, hepatitis B, Haemophilus influenzae type b, meningococcal serogroup C disease.\n* History of allergic disease or reactions likely to be exacerbated by any component of the vaccines.\n* History of seizures (this criterion does not apply to subjects who have had a single, uncomplicated febrile convulsion in the past) or progressive neurological disease.\n* Acute disease at the time of enrolment.\n* Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination.\n* A family history of congenital or hereditary immunodeficiency.\n* Major congenital defects or serious chronic illness.\n* Administration of immunoglobulins and/or any blood products within three months preceding the booster dose of study vaccines or planned administration during the active phase of the study (starting with the administration of the booster dose of study vaccines up to the follow-up visit one month after).","healthyVolunteers":true,"sex":"ALL","minimumAge":"11 Months","maximumAge":"18 Months","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects Reporting Fever Above 39.0 Degree Celsius (°C)","description":"Fever was measured as rectal temperature.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"11","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Solicited Local Symptoms","description":"Solicited local symptoms assessed include pain, redness and swelling.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"196","spread":null},{"groupId":"OG001","value":"195","spread":null},{"groupId":"OG002","value":"193","spread":null},{"groupId":"OG003","value":"165","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"194","spread":null},{"groupId":"OG001","value":"183","spread":null},{"groupId":"OG002","value":"186","spread":null},{"groupId":"OG003","value":"173","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"162","spread":null},{"groupId":"OG001","value":"148","spread":null},{"groupId":"OG002","value":"150","spread":null},{"groupId":"OG003","value":"134","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Solicited General Symptoms","description":"Solicited general symptoms assessed include drowsiness, fever, irritability, and loss of appetite.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null},{"groupId":"OG001","value":"142","spread":null},{"groupId":"OG002","value":"139","spread":null},{"groupId":"OG003","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"109","spread":null},{"groupId":"OG001","value":"122","spread":null},{"groupId":"OG002","value":"105","spread":null},{"groupId":"OG003","value":"108","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"170","spread":null},{"groupId":"OG001","value":"190","spread":null},{"groupId":"OG002","value":"191","spread":null},{"groupId":"OG003","value":"157","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"101","spread":null},{"groupId":"OG001","value":"99","spread":null},{"groupId":"OG002","value":"112","spread":null},{"groupId":"OG003","value":"93","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Unsolicited Adverse Events (AE)","description":"An AE is any untoward medical occurrence in a clinical investigation subject, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"74","spread":null},{"groupId":"OG002","value":"59","spread":null},{"groupId":"OG003","value":"76","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Serious Adverse Events (SAE)","description":"An SAE is any untoward medical occurrence that: results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study subject, or may evolve into one of the outcomes listed above.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Serious Adverse Events (SAE)","description":"An SAE is any untoward medical occurrence that: results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study subject, or may evolve into one of the outcomes listed above.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"13","spread":null},{"groupId":"OG003","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Vaccine Pneumococcal Serotype Antibody Concentrations Above the Cut-off Value","description":"Anti-pneumococcal antibody concentration cut-off value assessed was 0.05 microgram per milliliter (µg/mL).\n\nThe vaccine pneumococcal serotypes assessed include 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"146","spread":null},{"groupId":"OG001","value":"146","spread":null},{"groupId":"OG002","value":"140","spread":null},{"groupId":"OG003","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"152","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"152","spread":null},{"groupId":"OG001","value":"156","spread":null},{"groupId":"OG002","value":"147","spread":null},{"groupId":"OG003","value":"150","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"152","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"146","spread":null},{"groupId":"OG002","value":"144","spread":null},{"groupId":"OG003","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"157","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"144","spread":null},{"groupId":"OG003","value":"137","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"157","spread":null},{"groupId":"OG001","value":"151","spread":null},{"groupId":"OG002","value":"158","spread":null},{"groupId":"OG003","value":"153","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"147","spread":null},{"groupId":"OG003","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"152","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"154","spread":null},{"groupId":"OG002","value":"149","spread":null},{"groupId":"OG003","value":"152","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"152","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"153","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"151","spread":null},{"groupId":"OG001","value":"157","spread":null},{"groupId":"OG002","value":"152","spread":null},{"groupId":"OG003","value":"151","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"153","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"151","spread":null},{"groupId":"OG002","value":"145","spread":null},{"groupId":"OG003","value":"151","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"157","spread":null},{"groupId":"OG001","value":"152","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"152","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"143","spread":null},{"groupId":"OG001","value":"146","spread":null},{"groupId":"OG002","value":"139","spread":null},{"groupId":"OG003","value":"143","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"151","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"152","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"144","spread":null},{"groupId":"OG003","value":"141","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"152","spread":null},{"groupId":"OG002","value":"158","spread":null},{"groupId":"OG003","value":"153","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Opsonophagocytic Activity Against Vaccine Pneumococcal Serotypes Above the Cut-off Value","description":"Cut-off value for opsonophagocytic activity against pneumococcal antibody assessed was ≥ 8.\n\nThe vaccine pneumococcal serotypes assessed include 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"39","spread":null},{"groupId":"OG002","value":"41","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"133","spread":null},{"groupId":"OG002","value":"127","spread":null},{"groupId":"OG003","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"61","spread":null},{"groupId":"OG003","value":"73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137","spread":null},{"groupId":"OG001","value":"134","spread":null},{"groupId":"OG002","value":"140","spread":null},{"groupId":"OG003","value":"135","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77","spread":null},{"groupId":"OG001","value":"71","spread":null},{"groupId":"OG002","value":"72","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121","spread":null},{"groupId":"OG001","value":"127","spread":null},{"groupId":"OG002","value":"131","spread":null},{"groupId":"OG003","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75","spread":null},{"groupId":"OG001","value":"60","spread":null},{"groupId":"OG002","value":"75","spread":null},{"groupId":"OG003","value":"67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"127","spread":null},{"groupId":"OG002","value":"135","spread":null},{"groupId":"OG003","value":"138","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"109","spread":null},{"groupId":"OG001","value":"117","spread":null},{"groupId":"OG002","value":"109","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"140","spread":null},{"groupId":"OG001","value":"137","spread":null},{"groupId":"OG002","value":"139","spread":null},{"groupId":"OG003","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"131","spread":null},{"groupId":"OG001","value":"130","spread":null},{"groupId":"OG002","value":"122","spread":null},{"groupId":"OG003","value":"126","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"143","spread":null},{"groupId":"OG001","value":"139","spread":null},{"groupId":"OG002","value":"143","spread":null},{"groupId":"OG003","value":"137","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115","spread":null},{"groupId":"OG001","value":"116","spread":null},{"groupId":"OG002","value":"107","spread":null},{"groupId":"OG003","value":"124","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137","spread":null},{"groupId":"OG001","value":"138","spread":null},{"groupId":"OG002","value":"138","spread":null},{"groupId":"OG003","value":"134","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null},{"groupId":"OG001","value":"54","spread":null},{"groupId":"OG002","value":"34","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121","spread":null},{"groupId":"OG001","value":"127","spread":null},{"groupId":"OG002","value":"121","spread":null},{"groupId":"OG003","value":"110","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"102","spread":null},{"groupId":"OG001","value":"110","spread":null},{"groupId":"OG002","value":"95","spread":null},{"groupId":"OG003","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"133","spread":null},{"groupId":"OG001","value":"132","spread":null},{"groupId":"OG002","value":"139","spread":null},{"groupId":"OG003","value":"131","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121","spread":null},{"groupId":"OG001","value":"120","spread":null},{"groupId":"OG002","value":"105","spread":null},{"groupId":"OG003","value":"124","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"145","spread":null},{"groupId":"OG001","value":"143","spread":null},{"groupId":"OG002","value":"146","spread":null},{"groupId":"OG003","value":"143","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Cross-reactive Pneumococcal Serotype Antibody Concentrations Above the Cut-off Value","description":"Anti-pneumococcal antibody cut-off value assessed was 0.05 microgram per milliliter (µg/mL).\n\nThe cross-reactive pneumococcal serotypes assessed include 6A and 19A.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"126","spread":null},{"groupId":"OG001","value":"120","spread":null},{"groupId":"OG002","value":"119","spread":null},{"groupId":"OG003","value":"110","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"152","spread":null},{"groupId":"OG001","value":"145","spread":null},{"groupId":"OG002","value":"149","spread":null},{"groupId":"OG003","value":"148","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130","spread":null},{"groupId":"OG001","value":"138","spread":null},{"groupId":"OG002","value":"121","spread":null},{"groupId":"OG003","value":"87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"154","spread":null},{"groupId":"OG001","value":"151","spread":null},{"groupId":"OG002","value":"155","spread":null},{"groupId":"OG003","value":"149","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Opsonophagocytic Activity Against Cross-reactive Pneumococcal Serotypes Above the Cut-off Value","description":"Anti-pneumococcal antibody cut-off value assessed was ≥ 8.\n\nThe cross-reactive pneumococcal serotypes assessed include 6A and 19A.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"66","spread":null},{"groupId":"OG002","value":"73","spread":null},{"groupId":"OG003","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116","spread":null},{"groupId":"OG001","value":"119","spread":null},{"groupId":"OG002","value":"117","spread":null},{"groupId":"OG003","value":"119","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77","spread":null},{"groupId":"OG001","value":"75","spread":null},{"groupId":"OG002","value":"50","spread":null},{"groupId":"OG003","value":"29","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-protein D Antibody Concentrations Above the Cut-off Value","description":"Anti-protein D antibody cut-off value assessed was ≥ 100 Enzyme-Linked Immuno Sorbent Assay (ELISA) unit per milliliter (EL.U/mL).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"144","spread":null},{"groupId":"OG001","value":"147","spread":null},{"groupId":"OG002","value":"138","spread":null},{"groupId":"OG003","value":"59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"151","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"66","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Meningococcal Serogroup C Serum Bactericidal Assay Titer Above the Cut-off Value","description":"Meningococcal serogroup C serum bactericidal assay titer cut-off value assessed was ≥ 8.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"62","spread":null},{"groupId":"OG002","value":"62","spread":null},{"groupId":"OG003","value":"68","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"89","spread":null},{"groupId":"OG001","value":"84","spread":null},{"groupId":"OG002","value":"79","spread":null},{"groupId":"OG003","value":"76","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-meningococcal Polysaccharide C Antibody Concentrations Above the Cut-off Value","description":"Anti-meningococcal polysaccharide C antibody cut-off value assessed was ≥ 0.3 µg/mL.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"82","spread":null},{"groupId":"OG002","value":"105","spread":null},{"groupId":"OG003","value":"102","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"156","spread":null},{"groupId":"OG001","value":"149","spread":null},{"groupId":"OG002","value":"159","spread":null},{"groupId":"OG003","value":"149","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Anti-polyribosyl-ribitol Phosphate Antibody Concentrations Above the Cut-off Value","description":"Anti-polyribosyl-ribitol phosphate antibody cut-off value assessed was ≥ 0.15 µg/mL.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"122","spread":null},{"groupId":"OG001","value":"128","spread":null},{"groupId":"OG002","value":"145","spread":null},{"groupId":"OG003","value":"143","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"157","spread":null},{"groupId":"OG001","value":"153","spread":null},{"groupId":"OG002","value":"160","spread":null},{"groupId":"OG003","value":"152","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":15},"commonTop":["Pain","Redness","Irritability","Swelling","Drowsiness"]}}}